Cambridge Trust CO Viatris Inc Transaction History
Cambridge Trust CO
- $2.6 Billion
- Q1 2024
A detailed history of Cambridge Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Cambridge Trust CO holds 2,773 shares of VTRS stock, worth $32,028. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,773
Previous 2,760
0.47%
Holding current value
$32,028
Previous $29,000
13.79%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VTRS
# of Institutions
1,100Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.62 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$717 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$665 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$656 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...